Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder.
A 73-year-old man with primary small-cell carcinoma of the bladder was treated by radical cystectomy with neoadjuvant chemotherapy. Pathological complete remission was achieved by combination chemotherapy composed of cisplatin, etoposide and irinotecan. The patient is free of disease 19 months after surgery.
Kawahara
Takashi
T
Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Nishiyama
Hiroyuki
H
Yamamoto
Shingo
S
Kamoto
Toshiyuki
T
Ogawa
Osamu
O
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D000077146:Irinotecan; D008297:Male; D020360:Neoadjuvant Therapy; D012074:Remission Induction; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D005047:Etoposide; D000077146:Irinotecan; D002945:Cisplatin; D002166:Camptothecin